Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

NanoString comparison of immune gene expression between AIR patients, RP patients and controls

ABSTRACT: NanoString comparison of immune gene expression between AIR patients, RP patients and controls

PROVIDER: PRJNA483183 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

NanoString comparison of immune gene expression between AIR patients, RP patients and controls

Project description:Autoimmune retinopathy patient whole blood mRNA was compared to patients with retinitis pigmentosa and non-eye disease controls.

2018-07-28 | GSE117751 | GEO

Nanostring based analysis of CBF-AML patients

Project description:Nanostring based analysis of CBF-AML patients

| PRJNA803535 | ENA

A cross-comparison of technologies for the detection of microRNAs from FFPE samples of hepatoblastoma patients [NanoString]

Project description:This work highlights similarities and differences between three platforms (next-generation sequencing, microarray and NanoString) for detecting miRNAs and compares their strengths and weaknesses. miRNA expression profiles were determined in Hepatoblastoma FFPE samples using a NanoString platform.

2015-05-03 | E-GEOD-62017 | biostudies-arrayexpress

Comparison of microRNA Profiling Platforms (NanoString)

Project description:Global miRNA expression profiling of human malignancies is gaining popularity in both basic and clinically driven research. But to date, the majority of such analyses have used microarrays and quantitative real-time PCR. With the introduction of digital count technologies, such as next-generation sequencing (NGS) and the NanoString nCounter System, we have at our disposal, many more options. To make effective use of these different platforms, the strengths and pitfalls of several miRNA profiling technologies were assessed, including a microarray platform, NGS technologies and the NanoString nCounter System. These results were compared to gold-standard quantitative real-time PCR. Comparison of non-small cell lung cancer cell lines grown in vitro (n = 5) and in vivo (n = 5) as xenograft models.

2013-10-22 | E-GEOD-51504 | biostudies-arrayexpress

mRNA Seq analysis of Drosophila wing imaginal discs from Rp mutants and controls in the presence and absence of RpS12 mutations RpS12

Project description:mRNA Seq analysis of Drosophila wing imaginal discs from Rp mutants and controls in the presence and absence of RpS12 mutations RpS12 is a regulatory gene required for Xrp1-mediated control of translation and growth in mutants for other ribosomal protein genes Loss of function mutations in Ribosomal Protein (Rp) genes are generally lethal, but heterozygous mutant phenotypes increasingly reveal previously cryptic functions of Rps in growth control and tumor suppression. Here we report that RpS12 in particular is a regulatory gene that controls its own expression levels and also signals to control hundreds of gene expression changes in mutants for haploinsufficient Rp genes, acting through the bZip protein Xrp1. Through Xrp1, RpS12 reduces the bulk translation rate of Rp mutant cells and increases the developmental rate of Rp mutant genotypes. RpS12 also has an Xrp1-independent, positive contribution to normal development, so that the effects of RpS12 mutations in different genetic backgrounds reflects the sum of the Xrp1-dependent and Xrp1-independent effects. Our findings outline a regulatory response to mutations affecting essential Rp genes that controls overall translation and growth.

2019-12-17 | GSE124924 | GEO

Nanostring Wnt Pathway Panel of Metastatic Melanoma Patients Prior to Anti-PD-1 Treatment

Project description:FFPE tumor samples from metastatic melanoma patients were extracted and a Nanostring Wnt Pathway panel was performed

2021-01-29 | GSE165745 | GEO

Comparison of microRNA Profiling Platforms (NanoString)

2013-10-22 | GSE51504 | GEO

Whole genome characterisation of chemoresistant ovarian cancer [NanoString miRNA]

Project description:Patients with high-grade serous ovarian cancer (HGSC) have experienced little improvement in overall survival, and standard treatment has not advanced beyond platinum-based combination chemotherapy, during the past 30 years. To understand the drivers of clinical phenotypes better, here we use whole-genome sequencing of tumour and germline DNA samples from 92 patients with primary refractory, resistant, sensitive and matched acquired resistant disease. We show that gene breakage commonly inactivates the tumour suppressors RB1, NF1, RAD51B and PTEN in HGSC, and contributes to acquired chemotherapy resistance. CCNE1 amplification was common in primary resistant and refractory disease. We observed several molecular events associated with acquired resistance, including multiple independent reversions of germline BRCA1 or BRCA2 mutations in individual patients, loss of BRCA1 promoter methylation, an alteration in molecular subtype, and recurrent promoter fusion associated with overexpression of the drug efflux pump MDR1. Total RNA was hybridised to NanoString miRNA Human v2.1 probes, immobilized to NanoString cartridge and analysed on the NanoString Digital Analyzer. NanoString nSolver Analysis Software was utilised to check QC metrics and extract raw miRNA counts. Expression was normalised for input using the housekeeping genes. Contributor: The Australian Ovarian Cancer Study Group

2015-05-19 | E-GEOD-65819 | biostudies-arrayexpress

Nanostring plasma microRNA profiling in hospitalised patients with COVID-19

Project description:Nanostring plasma microRNA profiling in hospitalised patients with COVID-19

| PRJNA783883 | ENA

Air

Project description:Air Metagenome

| PRJNA1108853 | ENA